SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-08-003238
Filing Date
2008-05-01
Accepted
2008-05-01 16:32:26
Documents
5
Period of Report
2008-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CRITICAL THERAPEUTICS, INC. b69977cte8vk.htm 8-K 29620
2 EX-2.1 AGREEMENT AND PLAN OF MERGER b69977ctexv2w1.htm EX-2.1 616688
3 EX-99.1 PRESS RELEASE DATED MAY 1, 2008 b69977ctexv99w1.htm EX-99.1 28510
4 GRAPHIC b69977ctb6997700.gif GRAPHIC 2511
5 GRAPHIC b69977ctb6997701.gif GRAPHIC 5151
  Complete submission text file 0000950135-08-003238.txt   687279
Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700
CRITICAL THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50767 | Film No.: 08795173
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1